Acute Myeloid Leukemia in Pediatric Patients: A Review About Current Diagnostic and Treatment Approaches

Cancer Genome Atlas Research Network, None, Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia The New England Journal of Medicine. ,vol. 368, pp. 2059- 2074 ,(2013) , 10.1056/NEJMOA1301689

Ting‐Chi Yeh, Hsi‐Che Liu, Jen‐Yin Hou, Kuan‐Hao Chen, Ting‐Huan Huang, Ching‐Yi Chang, Der‐Cherng Liang, None, Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis. Cancer. ,vol. 120, pp. 1255- 1262 ,(2014) , 10.1002/CNCR.28524

Brenda E. S. Gibson, David K. H. Webb, Andrew J. Howman, Siebold S. N. De Graaf, Christine J. Harrison, Keith Wheatley, , Results of a randomized trial in children with Acute Myeloid Leukaemia: Medical Research Council AML12 trial British Journal of Haematology. ,vol. 155, pp. 366- 376 ,(2011) , 10.1111/J.1365-2141.2011.08851.X

Ari Melnick, Jonathan D. Licht, Deconstructing a Disease: RAR, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia Blood. ,vol. 93, pp. 3167- 3215 ,(1999) , 10.1182/BLOOD.V93.10.3167.410K44_3167_3215

Donna L. Johnston, Todd A. Alonzo, Robert B. Gerbing, Betsy Hirsch, Nyla A. Heerema, Yaddanapudi Ravindranath, William G. Woods, Beverly J. Lange, Alan S. Gamis, Susana C. Raimondi, Outcome of pediatric patients with acute myeloid leukemia (AML) and −5/5q− abnormalities from five pediatric AML treatment protocols: A report from the Children's Oncology Group Pediatric Blood & Cancer. ,vol. 60, pp. 2073- 2078 ,(2013) , 10.1002/PBC.24573

PA Cassileth, E Lynch, JD Hines, MM Oken, JJ Mazza, JM Bennett, PB McGlave, M Edelstein, DP Harrington, MJ O'Connell, Varying intensity of postremission therapy in acute myeloid leukemia. Blood. ,vol. 79, pp. 1924- 1930 ,(1992) , 10.1182/BLOOD.V79.8.1924.1924

Michael J. Kelly, John T. Horan, Todd A. Alonzo, Mary Eapen, Robert B. Gerbing, Wensheng He, Beverly J. Lange, Susan K. Parsons, William G. Woods, Comparable survival for pediatric acute myeloid leukemia with poor-risk cytogenetics following chemotherapy, matched related donor, or unrelated donor transplantation. Pediatric Blood & Cancer. ,vol. 61, pp. 269- 275 ,(2014) , 10.1002/PBC.24739

Paola Quarello, Franca Fagioli, Giuseppe Basso, Maria C. Putti, Massimo Berger, Matteo Luciani, Carmelo Rizzari, Giuseppe Menna, Riccardo Masetti, Franco Locatelli, Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trial British Journal of Haematology. ,vol. 171, pp. 566- 573 ,(2015) , 10.1111/BJH.13611

Eva A. Coenen, Susana C. Raimondi, Jochen Harbott, Martin Zimmermann, Todd A. Alonzo, Anne Auvrignon, H. Berna Beverloo, Myron Chang, Ursula Creutzig, Michael N. Dworzak, Erik Forestier, Brenda Gibson, Henrik Hasle, Christine J. Harrison, Nyla A. Heerema, Gertjan J. L. Kaspers, Anna Leszl, Nathalia Litvinko, Luca Lo Nigro, Akira Morimoto, Christine Perot, Dirk Reinhardt, Jeffrey E. Rubnitz, Franklin O. Smith, Jan Stary, Irina Stasevich, Sabine Strehl, Takashi Taga, Daisuke Tomizawa, David Webb, Zuzana Zemanova, Rob Pieters, C. Michel Zwaan, Marry M. van den Heuvel-Eibrink, Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study Blood. ,vol. 117, pp. 7102- 7111 ,(2011) , 10.1182/BLOOD-2010-12-328302

Tejpal Gupta, Sadhana Kannan, Vandana Dantkale, Siddharta Laskar, Cyclophosphamide plus total body irradiation compared with busulfan plus cyclophosphamide as a conditioning regimen prior to hematopoietic stem cell transplantation in patients with leukemia: a systematic review and meta-analysis Hematology/Oncology and Stem Cell Therapy. ,vol. 4, pp. 17- 29 ,(2011) , 10.5144/1658-3876.2011.17